Investigation announced for Long-Term Investors in ChemoCentryx, Inc. (NASDAQ: CCXI) over potential Wrongdoing – Press Release

An investigation on behalf of investors in ChemoCentryx, Inc. (NASDAQ: CCXI) shares over possible breaches of fiduciary duty.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ChemoCentryx, Inc..

Investors who are current long term investors in ChemoCentryx, Inc. (NASDAQ: CCXI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm for investors in NASDAQ: CCXI stocks follows a lawsuit filed against ChemoCentryx, Inc. over alleged securities laws violations. The investigation on behalf of current investors in NASDAQ: CCXI stocks, concerns whether certain ChemoCentryx, Inc.directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 26, 2019 and May 3, 2021, the defendants made false and/or misleading statements and/or failed to disclose that the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis, that the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan, that these issues presented a substantial concern regarding the viability of ChemoCentryx’s NDA for avacopan for the treatment of ANCA-associated vasculitis, and that as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

Those who purchased shares of ChemoCentryx, Inc. (NASDAQ: CCXI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

The post Investigation announced for Long-Term Investors in ChemoCentryx, Inc. (NASDAQ: CCXI) over potential Wrongdoing – Press Release appeared first on CaymanMama.com .

from CaymanMama.com https://ift.tt/3hmAZO4